Can Immunotherapy Address Intertumoral Heterogeneity?
Immunotherapy holds promise in addressing intertumoral heterogeneity. By harnessing the body's immune system to target cancer cells, immunotherapy can potentially overcome the diverse genetic and molecular landscapes of different tumors. However, the variability in immune responses among patients also underscores the need for personalized immunotherapeutic approaches.
